Centre Eugène Marquis
Rennes, France
48 recruiting
Showing 1–20 of 69 trials
Recruiting
Not Applicable
TARGETed Therapy Drug MONITOring in DIGestive Oncology
Hepatocellular CarcinomaMetastatic Colorectal CancerNeuroendocrine Tumors+2 more
UNICANCER330 enrolled29 locationsNCT05443087
Recruiting
Phase 2
Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC
Triple-Negative Breast Cancer
UNICANCER354 enrolled44 locationsNCT06078384
Recruiting
Not Applicable
Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)
Triple-Negative Breast Cancer
Institut Curie450 enrolled13 locationsNCT06225505
Recruiting
Phase 3
Flap Sparing in Postoperative Radiotherapy of Oral Cavity Cancers
Radiotherapy, AdjuvantOral Cavity CarcinomaFlap+1 more
Centre Francois Baclesse348 enrolled30 locationsNCT06798922
Recruiting
Phase 2
Skipping Hormone Therapy in Low-Risk Early Breast Cancer
Breast Cancer (Early Breast Cancer)
UNICANCER700 enrolled41 locationsNCT07661927
Recruiting
Phase 1Phase 2
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
Advanced Liver Cancers
Hoffmann-La Roche518 enrolled33 locationsNCT04524871
Recruiting
Phase 3
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple-Negative Breast Cancer
Gilead Sciences1,514 enrolled356 locationsNCT05633654
Recruiting
Predicting Response to Immunochemotherapy in Early Triple Negative Breast Cancer
Triple Negative Breast Cancer(TNBC)
Center Eugene Marquis200 enrolled1 locationNCT07570524
Recruiting
Not Applicable
ProActIF-01 Trial: Feasibility Study of an Individualized Program of Nutrition and Adapted Physical Activity in Frail Patients With Advanced Digestive Cancers
Cancer
Institut Curie50 enrolled18 locationsNCT05441163
Recruiting
Phase 3
Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma
Colorectal, Cancer
Canadian Cancer Trials Group834 enrolled55 locationsNCT07152821
Recruiting
Not Applicable
Prospective Multicenter Study Evaluating Feasibility and Efficacy of Tumor Organoid-based Precision Medicine in Patients With Advanced Refractory Cancers
Advanced, Pretreated Solid Tumors
Gustave Roussy, Cancer Campus, Grand Paris152 enrolled11 locationsNCT05267912
Recruiting
Phase 1Phase 2
Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas
LymphomaNSCLC (Non-small Cell Lung Cancer)Solid Advanced Tumor
OSE Immunotherapeutics41 enrolled11 locationsNCT05751798
Recruiting
Phase 2
MP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract Carcinoma
Advanced Biliary Tract Carcinoma
Centre Hospitalier Universitaire de Besancon75 enrolled11 locationsNCT07036380
Recruiting
Phase 2Phase 3
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib
Ovarian CarcinosarcomaEndometrial Carcinosarcoma
ARCAGY/ GINECO GROUP138 enrolled36 locationsNCT03651206
Recruiting
Phase 3
Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib
Breast Cancer
UNICANCER3,902 enrolled138 locationsNCT07237256
Recruiting
Not Applicable
COsegregation of VARiants in Panel of Genes
Genetic PredispositionGene Mutation-Related Cancer
Institut Curie11,000 enrolled62 locationsNCT01689584
Recruiting
Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008
Metastatic Breast Cancer
UNICANCER42,000 enrolled20 locationsNCT03275311
Recruiting
Phase 3
Personalized Medicine for Advanced Biliary Cancer Patients
Biliary Tract Neoplasms
UNICANCER800 enrolled69 locationsNCT05615818
Recruiting
Phase 2
Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients
Biliary Tract Cancer
UNICANCER72 enrolled41 locationsNCT06529718
Recruiting
Phase 2
Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis
Hepatocellular Carcinoma Non-resectable
Center Eugene Marquis80 enrolled6 locationsNCT07122089